Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis

Chronic obstructive pulmonary disease (COPD) is characterized by respiratory symptoms and non-reversible airflow limitation with recurrent episodes of acute exacerbations. The concurrent presence of bronchiectasis in patients with COPD is associated with reduced respiratory function as well as incre...

Full description

Bibliographic Details
Main Authors: Ersilia Nigro, Marco Mosella, Aurora Daniele, Marta Mallardo, Mariasofia Accardo, Andrea Bianco, Fabio Perrotta, Filippo Scialò
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/2/444
_version_ 1797619815891861504
author Ersilia Nigro
Marco Mosella
Aurora Daniele
Marta Mallardo
Mariasofia Accardo
Andrea Bianco
Fabio Perrotta
Filippo Scialò
author_facet Ersilia Nigro
Marco Mosella
Aurora Daniele
Marta Mallardo
Mariasofia Accardo
Andrea Bianco
Fabio Perrotta
Filippo Scialò
author_sort Ersilia Nigro
collection DOAJ
description Chronic obstructive pulmonary disease (COPD) is characterized by respiratory symptoms and non-reversible airflow limitation with recurrent episodes of acute exacerbations. The concurrent presence of bronchiectasis in patients with COPD is associated with reduced respiratory function as well as increased exacerbation risk. Adiponectin is a promising biomarker in COPD, as greater high molecular weight (HMW) oligomer levels have been observed among COPD patients. Here, we investigate adiponectin levels in two groups of COPD patients characterized by the presence or absence of bronchiectasis (BCO), comparing both groups to healthy controls. We evaluated serum adiponectin levels in COPD patients, those with BCO, and healthy subjects and characterized the pattern of circulating adiponectin oligomers. We found that forced volume capacity % (FVC%) and forced expiratory volume % (FEV1%) were lower for BCO patients than for COPD patients. COPD patients had higher levels of adiponectin and its HMW oligomers than healthy controls. Interestingly, BCO patients had higher levels of adiponectin than COPD patients. We showed that expression levels of IL-2, -4, and -8, IFN-γ, and GM-CSF were significantly higher in BCO patients than in healthy controls. Conversely, IL-10 expression levels were lower in BCO patients. Our data suggest that the increased levels of adiponectin detected in the cohort of BCO patients compared to those in COPD patients without bronchiectasis might be determined by their worse airway inflammatory state. This hypothesis suggests that adiponectin could be considered as a biomarker to recognize advanced COPD patients with bronchiectasis.
first_indexed 2024-03-11T08:32:13Z
format Article
id doaj.art-1f97481485b6464abc2ba724cbc9eb07
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-11T08:32:13Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-1f97481485b6464abc2ba724cbc9eb072023-11-16T21:41:21ZengMDPI AGLife2075-17292023-02-0113244410.3390/life13020444Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of BronchiectasisErsilia Nigro0Marco Mosella1Aurora Daniele2Marta Mallardo3Mariasofia Accardo4Andrea Bianco5Fabio Perrotta6Filippo Scialò7CEINGE, Biotecnologie Avanzate Scarl, 80145 Napoli, ItalyIstituti Clinici Scientifici Maugeri IRCCS, Pulmonary Rehabilitation Unit of Telese Terme Institute, 82037 Telese Terme, ItalyCEINGE, Biotecnologie Avanzate Scarl, 80145 Napoli, ItalyCEINGE, Biotecnologie Avanzate Scarl, 80145 Napoli, ItalyIstituti Clinici Scientifici Maugeri IRCCS, Pulmonary Rehabilitation Unit of Telese Terme Institute, 82037 Telese Terme, ItalyDepartment of Translational Medical Sciences, University of Campania L. Vanvitelli, 80138 Naples, ItalyDepartment of Translational Medical Sciences, University of Campania L. Vanvitelli, 80138 Naples, ItalyDepartment of Translational Medical Sciences, University of Campania L. Vanvitelli, 80138 Naples, ItalyChronic obstructive pulmonary disease (COPD) is characterized by respiratory symptoms and non-reversible airflow limitation with recurrent episodes of acute exacerbations. The concurrent presence of bronchiectasis in patients with COPD is associated with reduced respiratory function as well as increased exacerbation risk. Adiponectin is a promising biomarker in COPD, as greater high molecular weight (HMW) oligomer levels have been observed among COPD patients. Here, we investigate adiponectin levels in two groups of COPD patients characterized by the presence or absence of bronchiectasis (BCO), comparing both groups to healthy controls. We evaluated serum adiponectin levels in COPD patients, those with BCO, and healthy subjects and characterized the pattern of circulating adiponectin oligomers. We found that forced volume capacity % (FVC%) and forced expiratory volume % (FEV1%) were lower for BCO patients than for COPD patients. COPD patients had higher levels of adiponectin and its HMW oligomers than healthy controls. Interestingly, BCO patients had higher levels of adiponectin than COPD patients. We showed that expression levels of IL-2, -4, and -8, IFN-γ, and GM-CSF were significantly higher in BCO patients than in healthy controls. Conversely, IL-10 expression levels were lower in BCO patients. Our data suggest that the increased levels of adiponectin detected in the cohort of BCO patients compared to those in COPD patients without bronchiectasis might be determined by their worse airway inflammatory state. This hypothesis suggests that adiponectin could be considered as a biomarker to recognize advanced COPD patients with bronchiectasis.https://www.mdpi.com/2075-1729/13/2/444adiponectinbiomarkerchronic obstructive pulmonary diseasebronchiectasispro-inflammatory cytokines
spellingShingle Ersilia Nigro
Marco Mosella
Aurora Daniele
Marta Mallardo
Mariasofia Accardo
Andrea Bianco
Fabio Perrotta
Filippo Scialò
Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis
Life
adiponectin
biomarker
chronic obstructive pulmonary disease
bronchiectasis
pro-inflammatory cytokines
title Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis
title_full Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis
title_fullStr Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis
title_full_unstemmed Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis
title_short Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis
title_sort adiponectin increase in patients affected by chronic obstructive pulmonary disease with overlap of bronchiectasis
topic adiponectin
biomarker
chronic obstructive pulmonary disease
bronchiectasis
pro-inflammatory cytokines
url https://www.mdpi.com/2075-1729/13/2/444
work_keys_str_mv AT ersilianigro adiponectinincreaseinpatientsaffectedbychronicobstructivepulmonarydiseasewithoverlapofbronchiectasis
AT marcomosella adiponectinincreaseinpatientsaffectedbychronicobstructivepulmonarydiseasewithoverlapofbronchiectasis
AT auroradaniele adiponectinincreaseinpatientsaffectedbychronicobstructivepulmonarydiseasewithoverlapofbronchiectasis
AT martamallardo adiponectinincreaseinpatientsaffectedbychronicobstructivepulmonarydiseasewithoverlapofbronchiectasis
AT mariasofiaaccardo adiponectinincreaseinpatientsaffectedbychronicobstructivepulmonarydiseasewithoverlapofbronchiectasis
AT andreabianco adiponectinincreaseinpatientsaffectedbychronicobstructivepulmonarydiseasewithoverlapofbronchiectasis
AT fabioperrotta adiponectinincreaseinpatientsaffectedbychronicobstructivepulmonarydiseasewithoverlapofbronchiectasis
AT filipposcialo adiponectinincreaseinpatientsaffectedbychronicobstructivepulmonarydiseasewithoverlapofbronchiectasis